Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;3(1):10-9.
doi: 10.4103/0976-7800.98811.

Various treatment options for benign prostatic hyperplasia: A current update

Alankar Shrivastava  1 , Vipin B Gupta
Affiliations

Various treatment options for benign prostatic hyperplasia: A current update

Alankar Shrivastava et al. J Midlife Health. 2012 Jan.

Abstract

In benign prostatic hyperplasia (BPH) there will be a sudden impact on overall quality of life of patient. This disease occurs normally at the age of 40 or above and also is associated with sexual dysfunction. Thus, there is a need of update on current medications of this disease. The presented review provides information on medications available for BPH. Phytotherapies with some improvements in BPH are also included. Relevant articles were identified through a search of the English-language literature indexed on MEDLINE, PUBMED, Sciencedirect and the proceedings of scientific meetings. The search terms were BPH, medications for BPH, drugs for BPH, combination therapies for BPH, Phytotherapies for BPH, Ayurveda and BPH, BPH treatments in Ayurveda. Medications including watchful waitings, Alpha one adrenoreceptor blockers, 5-alpha reductase inhibitors, combination therapies including tamsulosin-dutasteride, doxazosin-finasteride, terazosin-finasteride, tolterodine-tamsulosin and rofecoxib-finasteride were found. Herbal remedies such as Cernilton, Saxifraga stolonifera, Zi-Shen Pill (ZSP), Orbignya speciosa, Phellodendron amurense, Ganoderma lucidum, Serenoa Repens, pumpkin extract and Lepidium meyenii (Red Maca) have some improvements on BPH are included. Other than these discussions on Ayurvedic medications, TURP and minimally invasive therapies (MITs) are also included. Recent advancements in terms of newly synthesized molecules are also discussed. Specific alpha one adrenoreceptor blockers such as tamsulosin and alfuzosin will remain preferred choice of urologists for symptom relief. Medications with combination therapies are still needs more investigation to establish as preference in initial stage for fast symptom relief reduced prostate growth and obviously reduce need for BPH-related surgery. Due to lack of proper evidence Phytotherapies are not gaining much advantage. MITs and TURP are expensive and are rarely supported by healthcare systems.

Keywords: 5 Alpha one reductase inhibitors; alpha one adrenoreceptor blockers; benign prostatic hyperplasia; therapies for BPH; treatment for BPH.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Anglin IE, Glassman DT, Kyprianou N. Induction of prostate apoptosis by α1 -adrenoceptor antagonists: Mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis. 2002;5:88–95. - PubMed
    1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33. - PubMed
    1. Boyle P. Prostate Cancer 2000; evolution of an epidemic of unknown origin. In: Dennis L, editor. Prostate Cancer. Heidelberg: Springer; 2000. pp. 5–11.
    1. Isaacs JT. Role of androgens in prostatic cancer. Vitam Horm. 1994;49:433–502. - PubMed
    1. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ confined prostate cancer is associated through prostate-specific antigen-based screening. JAMA. 1993;270:948–54. - PubMed